Alfonso Calvo

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Topics

Small Cell Lung Cancer

Top Venues

Journal for immunotherapy of cancer

International journal of molecular sciences

Methods in molecular biology (Clifton, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Clément Anfray, Aldo Ummarino, Alfonso Calvo, Paola Allavena, Fernando Torres Andón
In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment. Methods in molecular biology (Clifton, N.J.) 2614 (2023)
Paola Anna Jablonska, Nuria Galán, Jennifer Barranco, Sergio Leon, Ramón Robledano, José Ignacio Echeveste, Alfonso Calvo, Javier Aristu, Angel Rodriguez
Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases. International journal of molecular sciences 24 (18) (2023)
Francisco Expósito, Miriam Redrado, Maeva Houry, Katherine Hastings, Magdalena Molero, Teresa Lozano, José Luis Solórzano, Julián Sanz, Vera Adradas, Ramon Amat, Esther Redin, Sergio Leon, Naroa Legarra, Javier Garcia, Angel Rodriguez, Karmele Valencia, Camila Robles-Oteíza, Giorgia Foggetti, Nerea Otegui, Enriqueta Felip Font, Juan Jose Lasarte, Luis G Paz-Ares, Jon Zugazagoitia, Katerina Politi, Luis M Montuenga, Alfonso Calvo
PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer research (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Clément Anfray, Aldo Ummarino, Alfonso Calvo, Paola Allavena, Fernando Torres Andón
In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment. Methods in molecular biology (Clifton, N.J.) 2614 (2023)
Nerea Otegui, Maeva Houry, Imanol Arozarena, Angel Rodriguez, Esther Redin, Francisco Expósito, Sergio Leon, Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers 15 (12) (2023)
Karmele Valencia, Luis M Montuenga, Alfonso Calvo
Estrogen receptor and immune checkpoint inhibitors: new partners in lung cancer? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karmele Valencia, Mirari Echepare, Andrea Pasquier, Cristina Bértolo, Cristina Sainz, Ibon Tamayo-Uria, Beñat Picabea, Graziella Bosco, Roman K Thomas, Jackeline Agorreta, José María López-Picazo, Joan Frigola, Ramon Amat, Alfonso Calvo, Enriqueta Felip Font, Ignacio Melero Bermejo, Luis M Montuenga
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity. The Journal of experimental medicine 219 (12) (2022)
Celia Martín-Otal, Aritz Lasarte-Cia, Diego Serrano, Noelia Casares, Enrique Conde, Flor Navarro, Inés Sánchez-Moreno, Marta Gorraiz, Patricia Sarrión, Alfonso Calvo, Carlos E De Andrea, José Echeveste, Amaia Vilas, Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper, Sandra Hervás-Stubbs, Juan Jose Lasarte, Teresa Lozano
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells. Journal for immunotherapy of cancer 10 (8) (2022)
Fernando Torres Andón, Sergio Leon, Aldo Ummarino, Esther Redin, Paola Allavena, Angel Rodriguez, Clément Anfray, Alfonso Calvo
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists. Biomedicines 10 (7) (2022)
Irati Garmendia, Esther Redin, Luis M Montuenga, Alfonso Calvo
YES1: A Novel Therapeutic Target and Biomarker in Cancer. Molecular cancer therapeutics 21 (9) (2022)
Myrto K Moutafi, Magdalena Molero, Sandra Martinez Morilla, Javier Baena, Ioannis A Vathiotis, Niki Gavrielatou, Laura Castro-Labrador, Gorka Ruiz de Garibay, Vera Adradas, Daniel Orive, Karmele Valencia, Alfonso Calvo, Luis M Montuenga, S Ponce Aix, Kurt A Schalper, Roy S Herbst, Luis Paz-Ares, David L Rimm, Jon Zugazagoitia
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. Journal for immunotherapy of cancer 10 (8) (2022)
Clément Anfray, Francesco Mainini, Elisabeth Digifico, Akihiro Maeda, Marina Sironi, Marco Erreni, Achille Anselmo, Aldo Ummarino, Sara Gandoy, Francisco Expósito, Miriam Redrado, Diego Serrano, Alfonso Calvo, Marvin Martens, Susana Bravo, Alberto Mantovani, Paola Allavena, Fernando Torres Andón
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. Journal for immunotherapy of cancer 9 (9) (2022)
Mario Sánchez-Canteli, Luis Juesas, Irati Garmendia, María Otero-Rosales, Alfonso Calvo, Monica Alvarez-Fernández, Aurora Astudillo, Luis M Montuenga, Juana María García-Pedrero, Juan Pablo Rodrigo
Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas. International journal of molecular sciences 23 (19) (2022)
Esther Redin, Irati Garmendia, Teresa Lozano, Diego Serrano, Yaiza Senent, Miriam Redrado, Maria Villalba, Carlos E De Andrea, Francisco Expósito, Daniel Ajona, Sergio Ortiz-Espinosa, Ana Remirez, Cristina Bertolo, Cristina Sainz, Juana Garcia-Pedrero, Ruben Pio, Juan Jose Lasarte, Jackeline Agorreta, Luis M Montuenga, Alfonso Calvo
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation. Journal for immunotherapy of cancer 9 (3) (2021)
Mohamed Elgendy, Juan Pablo Fusco, Victor Segura, Maria Dolores Lozano, Saverio Minucci, Jose Ignacio Echeveste, Alfonso Gurpide, Mapi Andueza, Ignacio Melero, Miguel F Sanmamed, Maria Rodriguez Ruiz, Alfonso Calvo, Juan Ignacio Pascual, Jose María Velis, Bernardino Miñana, Ricardo Diez Valle, Ruben Pio, Jackeline Agorreta, Marta Abengozar, Maurizio Colecchia, Silvia Brich, Salvatore Lorenzo Renne, Elisabet Guruceaga, Ana Patiño-García, Jose-Luis Perez-Gracia
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer. International journal of cancer 145 (7) (2019)